Growing teratoma syndrome in intracranial non-germinomatous germ cell tumors (iNGGCTs): a risk for secondary malignant transformation—a report of two cases View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-05

AUTHORS

Torin Glass, D. Douglas Cochrane, Shahrad Rod Rassekh, Karen Goddard, Juliette Hukin

ABSTRACT

PURPOSE: About 5% of pediatric intracranial germ cell tumors and 20% of non-germinomatous germ cell tumors (NGGCT) progress to growing teratoma syndrome (GTS) following chemoradiotherapy. The growing teratoma is thought to arise from the chemotherapy-resistant, teratomatous portion of a germ cell tumor and is commonly benign but may undergo malignant transformation. METHODS: Two pediatric patients whose intracranial NGGCTs progressed to growing teratomas during chemotherapy and later transformed to secondary malignant tumors after partial resection and radiation therapy (RT). RESULTS: Both tumors were diagnosed by MRI scans and elevated serum and CSF markers. Following normalization of tumor markers with chemotherapy and initial decrease in tumor volume, subsequent imaging showed regrowth during chemotherapy with pathology revealing benign teratoma. RT was administered. Several years following this treatment, further growth was seen with pathology indicating malignant carcinoma in one patient and malignant rhabdomyosarcoma in the other. The patient with carcinoma received palliative care while the patient with the sarcoma received further resection, intensive chemotherapy, and an autologous stem cell transplant and is currently in remission, 36 months since malignant transformation. CONCLUSION: Malignant transformation of presumed residual teratoma has been seldom reported. Treatment of NGGCT involves platinum-based chemotherapy with craniospinal RT and boost to the primary site, with cure rates of around 80%. Teratomas are characteristically chemotherapy and RT resistant and are treated surgically. In the event that residual or growing teratoma is suspected, a complete resection should be considered early in the management as there is a risk of malignant transformation of residual teratoma. More... »

PAGES

953-957

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00381-013-2295-1

DOI

http://dx.doi.org/10.1007/s00381-013-2295-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013265665

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24122016


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Transformation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms, Germ Cell and Embryonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Teratoma", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "Division of Pediatric Neurology, British Columbia\u2019s Children\u2019s Hospital, University of British Columbia, 4480 Oak Street, V6H 3V4, Vancouver, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Glass", 
        "givenName": "Torin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "Division of Pediatric Neurosurgery, British Columbia\u2019s Children\u2019s Hospital, University of British Columbia, 4480 Oak Street, V6H 3V4, Vancouver, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cochrane", 
        "givenName": "D. Douglas", 
        "id": "sg:person.01022572536.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022572536.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "Division of Pediatric Hematology/Oncology/BMT, British Columbia\u2019s Children\u2019s Hospital, University of British Columbia, 4480 Oak Street, V6H 3V4, Vancouver, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rassekh", 
        "givenName": "Shahrad Rod", 
        "id": "sg:person.01200443405.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200443405.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "Division of Radiation Oncology, British Columbia Cancer Agency, University of British Columbia, 600 W 10th Ave, V5Z 4E6,, Vancouver, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goddard", 
        "givenName": "Karen", 
        "id": "sg:person.01122720174.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122720174.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "Division of Pediatric Neurology and Oncology, British Columbia\u2019s Children\u2019s Hospital, University of British Columbia, 4480 Oak Street, V6H 3V4, Vancouver, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hukin", 
        "givenName": "Juliette", 
        "id": "sg:person.01066370542.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066370542.69"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00701-009-0332-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006100194", 
          "https://doi.org/10.1007/s00701-009-0332-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00701-009-0332-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006100194", 
          "https://doi.org/10.1007/s00701-009-0332-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00701-009-0332-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006100194", 
          "https://doi.org/10.1007/s00701-009-0332-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.21307", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010947267"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19970901)80:5<942::aid-cncr16>3.0.co;2-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014811376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/b:neon.0000027670.96412.36", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015600769", 
          "https://doi.org/10.1023/b:neon.0000027670.96412.36"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19821015)50:8<1629::aid-cncr2820500828>3.0.co;2-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019385626"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19880901)62:5<982::aid-cncr2820620523>3.0.co;2-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028360418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00247-003-1045-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032891439", 
          "https://doi.org/10.1007/s00247-003-1045-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10014-006-0205-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039542829", 
          "https://doi.org/10.1007/s10014-006-0205-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10014-006-0205-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039542829", 
          "https://doi.org/10.1007/s10014-006-0205-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000478-199505000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041210779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000478-199505000-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041210779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e3181983af5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043335613"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e3181983af5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043335613"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e3181983af5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043335613"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2008-0037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044198735"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-010-0238-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051727089", 
          "https://doi.org/10.1007/s11060-010-0238-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-010-0238-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051727089", 
          "https://doi.org/10.1007/s11060-010-0238-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2009.1.peds0857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071074130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2009.1.peds0857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071074130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2009.1.peds0857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071074130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2009.1.peds0857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071074130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2009.1.peds0857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071074130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.2007.106.6.1067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071102333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.2007.106.6.1067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071102333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/jns.2007.106.6.1067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071102333"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-05", 
    "datePublishedReg": "2014-05-01", 
    "description": "PURPOSE: About 5% of pediatric intracranial germ cell tumors and 20% of non-germinomatous germ cell tumors (NGGCT) progress to growing teratoma syndrome (GTS) following chemoradiotherapy. The growing teratoma is thought to arise from the chemotherapy-resistant, teratomatous portion of a germ cell tumor and is commonly benign but may undergo malignant transformation.\nMETHODS: Two pediatric patients whose intracranial NGGCTs progressed to growing teratomas during chemotherapy and later transformed to secondary malignant tumors after partial resection and radiation therapy (RT).\nRESULTS: Both tumors were diagnosed by MRI scans and elevated serum and CSF markers. Following normalization of tumor markers with chemotherapy and initial decrease in tumor volume, subsequent imaging showed regrowth during chemotherapy with pathology revealing benign teratoma. RT was administered. Several years following this treatment, further growth was seen with pathology indicating malignant carcinoma in one patient and malignant rhabdomyosarcoma in the other. The patient with carcinoma received palliative care while the patient with the sarcoma received further resection, intensive chemotherapy, and an autologous stem cell transplant and is currently in remission, 36 months since malignant transformation.\nCONCLUSION: Malignant transformation of presumed residual teratoma has been seldom reported. Treatment of NGGCT involves platinum-based chemotherapy with craniospinal RT and boost to the primary site, with cure rates of around 80%. Teratomas are characteristically chemotherapy and RT resistant and are treated surgically. In the event that residual or growing teratoma is suspected, a complete resection should be considered early in the management as there is a risk of malignant transformation of residual teratoma.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00381-013-2295-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1095355", 
        "issn": [
          "0256-7040", 
          "1433-0350"
        ], 
        "name": "Child's Nervous System", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "30"
      }
    ], 
    "name": "Growing teratoma syndrome in intracranial non-germinomatous germ cell tumors (iNGGCTs): a risk for secondary malignant transformation\u2014a report of two cases", 
    "pagination": "953-957", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3f3238c75e993d0365b1866d2151bf5b63669eb0f9b19ef9c46e7785438c7729"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24122016"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8503227"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00381-013-2295-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013265665"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00381-013-2295-1", 
      "https://app.dimensions.ai/details/publication/pub.1013265665"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000480.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00381-013-2295-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00381-013-2295-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00381-013-2295-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00381-013-2295-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00381-013-2295-1'


 

This table displays all metadata directly associated to this object as RDF triples.

191 TRIPLES      21 PREDICATES      54 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00381-013-2295-1 schema:about N06ea4440c39b48a8b43649a4a72c4cb4
2 N0ffb568c123d4bdfb3d80b0c20297436
3 N1905d83659374f61bd5693387570ca10
4 N4e40e9f06b444ff1960a5f302d2e3ab4
5 N6923b52896a0417caa1f7dd679b9b468
6 N806a9442125142df98956bd223ddcdb9
7 Nae040d08749e4a6e8dba5349fc6d95c7
8 Nd107423628a141ed98591539d0862faa
9 Nd69e13426795418cb109de237edb3002
10 Nd72053cbad1843c69ccaae77c2190569
11 Nde58c6acc9d144bb94e93fa37c4d134b
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author Nf6cbc1f28cf746f8be066e30b1dff6ca
15 schema:citation sg:pub.10.1007/s00247-003-1045-z
16 sg:pub.10.1007/s00701-009-0332-3
17 sg:pub.10.1007/s10014-006-0205-x
18 sg:pub.10.1007/s11060-010-0238-1
19 sg:pub.10.1023/b:neon.0000027670.96412.36
20 https://doi.org/10.1002/(sici)1097-0142(19970901)80:5<942::aid-cncr16>3.0.co;2-w
21 https://doi.org/10.1002/1097-0142(19821015)50:8<1629::aid-cncr2820500828>3.0.co;2-1
22 https://doi.org/10.1002/1097-0142(19880901)62:5<982::aid-cncr2820620523>3.0.co;2-k
23 https://doi.org/10.1002/pbc.21307
24 https://doi.org/10.1097/00000478-199505000-00005
25 https://doi.org/10.1097/mph.0b013e3181983af5
26 https://doi.org/10.1634/theoncologist.2008-0037
27 https://doi.org/10.3171/2009.1.peds0857
28 https://doi.org/10.3171/jns.2007.106.6.1067
29 schema:datePublished 2014-05
30 schema:datePublishedReg 2014-05-01
31 schema:description PURPOSE: About 5% of pediatric intracranial germ cell tumors and 20% of non-germinomatous germ cell tumors (NGGCT) progress to growing teratoma syndrome (GTS) following chemoradiotherapy. The growing teratoma is thought to arise from the chemotherapy-resistant, teratomatous portion of a germ cell tumor and is commonly benign but may undergo malignant transformation. METHODS: Two pediatric patients whose intracranial NGGCTs progressed to growing teratomas during chemotherapy and later transformed to secondary malignant tumors after partial resection and radiation therapy (RT). RESULTS: Both tumors were diagnosed by MRI scans and elevated serum and CSF markers. Following normalization of tumor markers with chemotherapy and initial decrease in tumor volume, subsequent imaging showed regrowth during chemotherapy with pathology revealing benign teratoma. RT was administered. Several years following this treatment, further growth was seen with pathology indicating malignant carcinoma in one patient and malignant rhabdomyosarcoma in the other. The patient with carcinoma received palliative care while the patient with the sarcoma received further resection, intensive chemotherapy, and an autologous stem cell transplant and is currently in remission, 36 months since malignant transformation. CONCLUSION: Malignant transformation of presumed residual teratoma has been seldom reported. Treatment of NGGCT involves platinum-based chemotherapy with craniospinal RT and boost to the primary site, with cure rates of around 80%. Teratomas are characteristically chemotherapy and RT resistant and are treated surgically. In the event that residual or growing teratoma is suspected, a complete resection should be considered early in the management as there is a risk of malignant transformation of residual teratoma.
32 schema:genre research_article
33 schema:inLanguage en
34 schema:isAccessibleForFree false
35 schema:isPartOf N4108202605894a06a8d35a6f050bac58
36 Na720dc96a413416392e267f9283c4e2c
37 sg:journal.1095355
38 schema:name Growing teratoma syndrome in intracranial non-germinomatous germ cell tumors (iNGGCTs): a risk for secondary malignant transformation—a report of two cases
39 schema:pagination 953-957
40 schema:productId N01b50e3090cd40989720ad9fd31b9e45
41 N119aa4fe561748569657d780169e0d3a
42 N912a99293ce1442fa8303fc37064bcf8
43 Nb4d479bae5a34ff29e18221bad533c04
44 Nb5986b55e2424c95a2e65cdf00f69245
45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013265665
46 https://doi.org/10.1007/s00381-013-2295-1
47 schema:sdDatePublished 2019-04-11T01:00
48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
49 schema:sdPublisher N736921cffaf04139ae344da36e09ef62
50 schema:url http://link.springer.com/10.1007/s00381-013-2295-1
51 sgo:license sg:explorer/license/
52 sgo:sdDataset articles
53 rdf:type schema:ScholarlyArticle
54 N01b50e3090cd40989720ad9fd31b9e45 schema:name pubmed_id
55 schema:value 24122016
56 rdf:type schema:PropertyValue
57 N06ea4440c39b48a8b43649a4a72c4cb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Follow-Up Studies
59 rdf:type schema:DefinedTerm
60 N0ffb568c123d4bdfb3d80b0c20297436 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Combined Modality Therapy
62 rdf:type schema:DefinedTerm
63 N10175efd9f594f429f8540ba1ac953f4 rdf:first sg:person.01200443405.17
64 rdf:rest Nf7e114af58c24a7095db4cd83412b0a7
65 N119aa4fe561748569657d780169e0d3a schema:name nlm_unique_id
66 schema:value 8503227
67 rdf:type schema:PropertyValue
68 N1905d83659374f61bd5693387570ca10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Antineoplastic Combined Chemotherapy Protocols
70 rdf:type schema:DefinedTerm
71 N4108202605894a06a8d35a6f050bac58 schema:issueNumber 5
72 rdf:type schema:PublicationIssue
73 N4e40e9f06b444ff1960a5f302d2e3ab4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Male
75 rdf:type schema:DefinedTerm
76 N6923b52896a0417caa1f7dd679b9b468 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Cell Transformation, Neoplastic
78 rdf:type schema:DefinedTerm
79 N736921cffaf04139ae344da36e09ef62 schema:name Springer Nature - SN SciGraph project
80 rdf:type schema:Organization
81 N75879e6724bd45098c8ce9a1ceaa10d3 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
82 schema:familyName Glass
83 schema:givenName Torin
84 rdf:type schema:Person
85 N806a9442125142df98956bd223ddcdb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Brain Neoplasms
87 rdf:type schema:DefinedTerm
88 N8fddad76a4a24cd3b9d78c739fd57cb5 rdf:first sg:person.01066370542.69
89 rdf:rest rdf:nil
90 N912a99293ce1442fa8303fc37064bcf8 schema:name readcube_id
91 schema:value 3f3238c75e993d0365b1866d2151bf5b63669eb0f9b19ef9c46e7785438c7729
92 rdf:type schema:PropertyValue
93 Na720dc96a413416392e267f9283c4e2c schema:volumeNumber 30
94 rdf:type schema:PublicationVolume
95 Nae040d08749e4a6e8dba5349fc6d95c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Magnetic Resonance Imaging
97 rdf:type schema:DefinedTerm
98 Nb4d479bae5a34ff29e18221bad533c04 schema:name dimensions_id
99 schema:value pub.1013265665
100 rdf:type schema:PropertyValue
101 Nb5986b55e2424c95a2e65cdf00f69245 schema:name doi
102 schema:value 10.1007/s00381-013-2295-1
103 rdf:type schema:PropertyValue
104 Nd107423628a141ed98591539d0862faa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Humans
106 rdf:type schema:DefinedTerm
107 Nd69e13426795418cb109de237edb3002 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Teratoma
109 rdf:type schema:DefinedTerm
110 Nd72053cbad1843c69ccaae77c2190569 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Child
112 rdf:type schema:DefinedTerm
113 Nde58c6acc9d144bb94e93fa37c4d134b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Neoplasms, Germ Cell and Embryonal
115 rdf:type schema:DefinedTerm
116 Ne75da363128543af9cb649bb31478492 rdf:first sg:person.01022572536.41
117 rdf:rest N10175efd9f594f429f8540ba1ac953f4
118 Nf6cbc1f28cf746f8be066e30b1dff6ca rdf:first N75879e6724bd45098c8ce9a1ceaa10d3
119 rdf:rest Ne75da363128543af9cb649bb31478492
120 Nf7e114af58c24a7095db4cd83412b0a7 rdf:first sg:person.01122720174.64
121 rdf:rest N8fddad76a4a24cd3b9d78c739fd57cb5
122 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
123 schema:name Medical and Health Sciences
124 rdf:type schema:DefinedTerm
125 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
126 schema:name Oncology and Carcinogenesis
127 rdf:type schema:DefinedTerm
128 sg:journal.1095355 schema:issn 0256-7040
129 1433-0350
130 schema:name Child's Nervous System
131 rdf:type schema:Periodical
132 sg:person.01022572536.41 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
133 schema:familyName Cochrane
134 schema:givenName D. Douglas
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022572536.41
136 rdf:type schema:Person
137 sg:person.01066370542.69 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
138 schema:familyName Hukin
139 schema:givenName Juliette
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066370542.69
141 rdf:type schema:Person
142 sg:person.01122720174.64 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
143 schema:familyName Goddard
144 schema:givenName Karen
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122720174.64
146 rdf:type schema:Person
147 sg:person.01200443405.17 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
148 schema:familyName Rassekh
149 schema:givenName Shahrad Rod
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200443405.17
151 rdf:type schema:Person
152 sg:pub.10.1007/s00247-003-1045-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1032891439
153 https://doi.org/10.1007/s00247-003-1045-z
154 rdf:type schema:CreativeWork
155 sg:pub.10.1007/s00701-009-0332-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006100194
156 https://doi.org/10.1007/s00701-009-0332-3
157 rdf:type schema:CreativeWork
158 sg:pub.10.1007/s10014-006-0205-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039542829
159 https://doi.org/10.1007/s10014-006-0205-x
160 rdf:type schema:CreativeWork
161 sg:pub.10.1007/s11060-010-0238-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051727089
162 https://doi.org/10.1007/s11060-010-0238-1
163 rdf:type schema:CreativeWork
164 sg:pub.10.1023/b:neon.0000027670.96412.36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015600769
165 https://doi.org/10.1023/b:neon.0000027670.96412.36
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1002/(sici)1097-0142(19970901)80:5<942::aid-cncr16>3.0.co;2-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1014811376
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1002/1097-0142(19821015)50:8<1629::aid-cncr2820500828>3.0.co;2-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019385626
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1002/1097-0142(19880901)62:5<982::aid-cncr2820620523>3.0.co;2-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1028360418
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1002/pbc.21307 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010947267
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1097/00000478-199505000-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041210779
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1097/mph.0b013e3181983af5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043335613
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1634/theoncologist.2008-0037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044198735
180 rdf:type schema:CreativeWork
181 https://doi.org/10.3171/2009.1.peds0857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071074130
182 rdf:type schema:CreativeWork
183 https://doi.org/10.3171/jns.2007.106.6.1067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071102333
184 rdf:type schema:CreativeWork
185 https://www.grid.ac/institutes/grid.17091.3e schema:alternateName University of British Columbia
186 schema:name Division of Pediatric Hematology/Oncology/BMT, British Columbia’s Children’s Hospital, University of British Columbia, 4480 Oak Street, V6H 3V4, Vancouver, Canada
187 Division of Pediatric Neurology and Oncology, British Columbia’s Children’s Hospital, University of British Columbia, 4480 Oak Street, V6H 3V4, Vancouver, Canada
188 Division of Pediatric Neurology, British Columbia’s Children’s Hospital, University of British Columbia, 4480 Oak Street, V6H 3V4, Vancouver, Canada
189 Division of Pediatric Neurosurgery, British Columbia’s Children’s Hospital, University of British Columbia, 4480 Oak Street, V6H 3V4, Vancouver, Canada
190 Division of Radiation Oncology, British Columbia Cancer Agency, University of British Columbia, 600 W 10th Ave, V5Z 4E6,, Vancouver, Canada
191 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...